Teresa Bellón

7.9k total citations · 2 hit papers
102 papers, 5.9k citations indexed

About

Teresa Bellón is a scholar working on Immunology, Pharmacology and Rheumatology. According to data from OpenAlex, Teresa Bellón has authored 102 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology, 44 papers in Pharmacology and 21 papers in Rheumatology. Recurrent topics in Teresa Bellón's work include Drug-Induced Adverse Reactions (44 papers), Immune Cell Function and Interaction (26 papers) and T-cell and B-cell Immunology (23 papers). Teresa Bellón is often cited by papers focused on Drug-Induced Adverse Reactions (44 papers), Immune Cell Function and Interaction (26 papers) and T-cell and B-cell Immunology (23 papers). Teresa Bellón collaborates with scholars based in Spain, United States and Taiwan. Teresa Bellón's co-authors include Miguel López‐Botet, Francisco Navarro, Carmelo Bernabéu, Manuel Llano, Michelle Letarte, Marco Colonna, Carmela Calés, Joan Massagué, Sela Cheifetz and Pilar Garcı́a and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Teresa Bellón

101 papers receiving 5.7k citations

Hit Papers

A Common Inhibitory Receptor for Major Histocompatibility... 1992 2026 2003 2014 1997 1992 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Teresa Bellón Spain 38 2.9k 1.2k 1.1k 871 812 102 5.9k
Hiroaki Niiro Japan 43 2.8k 1.0× 1.3k 1.1× 262 0.2× 878 1.0× 843 1.0× 145 5.4k
B. Jack Longley United States 34 3.4k 1.2× 1.6k 1.4× 230 0.2× 1.7k 1.9× 847 1.0× 86 9.1k
Lisa A. Harlow United States 25 1.9k 0.7× 1.8k 1.5× 170 0.2× 1.0k 1.2× 1.7k 2.1× 35 5.3k
Timothy R. D. J. Radstake Netherlands 34 2.5k 0.9× 960 0.8× 105 0.1× 1.3k 1.5× 594 0.7× 81 4.5k
J S Pober United States 30 2.6k 0.9× 1.3k 1.1× 151 0.1× 277 0.3× 532 0.7× 39 5.6k
David M. Lee United States 26 2.7k 0.9× 905 0.8× 131 0.1× 1.0k 1.2× 472 0.6× 32 4.0k
Hayato Takahashi Japan 23 2.0k 0.7× 565 0.5× 138 0.1× 689 0.8× 642 0.8× 77 3.5k
Shiva Shahrara United States 37 1.7k 0.6× 1.1k 0.9× 129 0.1× 1.2k 1.4× 1.0k 1.3× 66 3.8k
Pilar Barrera Netherlands 36 1.8k 0.6× 757 0.6× 103 0.1× 1.6k 1.8× 1.0k 1.3× 97 4.6k
Shirou Fukuhara Japan 37 2.9k 1.0× 1.6k 1.3× 76 0.1× 490 0.6× 943 1.2× 143 5.7k

Countries citing papers authored by Teresa Bellón

Since Specialization
Citations

This map shows the geographic impact of Teresa Bellón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Bellón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Bellón more than expected).

Fields of papers citing papers by Teresa Bellón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Bellón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Bellón. The network helps show where Teresa Bellón may publish in the future.

Co-authorship network of co-authors of Teresa Bellón

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Bellón. A scholar is included among the top collaborators of Teresa Bellón based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Bellón. Teresa Bellón is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Sánchez, Rafáel, Javier Domínguez‐Ortega, Ana Fiandor, et al.. (2022). Characterization of hypersensitivity reactions to polysulfone hemodialysis membranes. Annals of Allergy Asthma & Immunology. 128(6). 713–720.e2. 4 indexed citations
3.
Olsson‐Brown, Anna, Vincent Yip, Lorenzo Ressel, et al.. (2022). TNF-α‒Mediated Keratinocyte Expression and Release of Matrix Metalloproteinase 9: Putative Mechanism of Pathogenesis in Stevens‒Johnson Syndrome/Toxic Epidermal Necrolysis. Journal of Investigative Dermatology. 143(6). 1023–1030.e7. 16 indexed citations
4.
Pan, Ren‐You, Mu-Tzu Chu, Chuang‐Wei Wang, et al.. (2019). Identification of drug-specific public TCR driving severe cutaneous adverse reactions. Nature Communications. 10(1). 3569–3569. 88 indexed citations
5.
Fiandor, Ana, Miguel Á. Muñoz, Santiago Quirce, et al.. (2019). The Lymphocyte Transformation Test Is Useful in the Diagnosis of Fixed Drug Eruption Induced by Etoricoxib. Journal of Investigational Allergology and Clinical Immunology. 29(4). 307–309. 9 indexed citations
6.
Carr, Daniel F., Chuang‐Wei Wang, Teresa Bellón, et al.. (2019). Serum and blister‐fluid elevation and decreased epidermal content of high‐mobility group box 1 protein in drug‐induced Stevens–Johnson syndrome/toxic epidermal necrolysis. British Journal of Dermatology. 181(1). 166–174. 15 indexed citations
7.
Ossorio, Marta, Virginia Martínez, M. Auxiliadora Bajo, et al.. (2018). Prominent Levels of the Profibrotic Chemokine CCL18 during Peritonitis:In VitroDownregulation by Vitamin D Receptor Agonists. BioMed Research International. 2018. 1–12. 4 indexed citations
8.
9.
Bellón, Teresa & Miguel Blanca. (2011). The innate immune system in delayed cutaneous allergic reactions to medications. Current Opinion in Allergy and Clinical Immunology. 11(4). 292–298. 12 indexed citations
10.
Morel, Esther, et al.. (2010). CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. Journal of Allergy and Clinical Immunology. 125(3). 703–710.e8. 54 indexed citations
11.
12.
Torres, Marı́a José, Elena Sánchez-Sabaté, Juan C. Álvarez, et al.. (2004). Skin test evaluation in nonimmediate allergic reactions to penicillins. Allergy. 59(2). 219–224. 74 indexed citations
13.
Sánchez-Sabaté, Elena, et al.. (2004). Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. Journal of Allergy and Clinical Immunology. 114(2). 335–340. 59 indexed citations
14.
Bellón, Teresa, et al.. (2002). Mutational Analysis of Immunoreceptor Tyrosine-Based Inhibition Motifs of the Ig-Like Transcript 2 (CD85j) Leukocyte Receptor. The Journal of Immunology. 168(7). 3351–3359. 54 indexed citations
15.
Posadas, S., Teresa Bellón, Tomás Blanco, et al.. (2002). Mechanism involved in fixed drug eruption. Journal of Allergy and Clinical Immunology. 109(1). S151–S151. 1 indexed citations
16.
Navarro, Francisco, Manuel Llano, Teresa Bellón, et al.. (1999). The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. European Journal of Immunology. 29(1). 277–283. 304 indexed citations
17.
Rodrı́guez, Antonio, Marta Carretero, Jens Glienke, et al.. (1998). Structure of the human CD94 C-type lectin gene. Immunogenetics. 47(4). 305–309. 29 indexed citations
18.
Cheifetz, Sela, Teresa Bellón, Carmela Calés, et al.. (1992). Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.. Journal of Biological Chemistry. 267(27). 19027–19030. 702 indexed citations breakdown →
19.
Bellón, Teresa, et al.. (1989). Synoviocytes Type A Bind Exogenous Antigens Recognized by Antibodies Present in Rheumatoid Arthritis. Scandinavian Journal of Immunology. 30(5). 563–571. 7 indexed citations
20.
Cabañas, Carlos, Francisco Sánchez‐Madrid, Agustín Acevedo, et al.. (1988). Characterization of a CD11c-Reactive Monoclonal Antibody (HC1/1) Obtained by Immunizing with Phorbo1 Ester Differentiated U937 Cells. Hybridoma. 7(2). 167–176. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026